Camarata (in press) highlights the impact that symptom hetereogeneity, overlap, and individual differences can have on the accurate early diagnosis of children with Autism Spectrum Disorder (ASD) and measurement of treatment outcomes. Nevertheless, these individual differences may provide avenues for predicting individual responses to treatment with the view to prospectively matching children with ASD to treatments best-suited to meeting their individual needs. In this commentary, we suggest that the behavioural characterstics that are critical to accurate early diferential diagnosis of ASD, may be poor predictors of outcomes. Whereas factors that are not unique to ASD may in fact be good predictors of treatment outcomes. We illustrate these points with reference to the results of recent studies demonstrating the problems, and possibilities, that individual differences currently present when it comes to understanding and promoting learning in children with ASD.
Introduction
In recent years, interest has grown regarding the relevance of individual differences in learning and response to treatment amongst children with ASD. Indeed, it is difficult to find a systematic review or treatment study in the field of ASD published in the past 5 years in which the authors do cite the need to better understand individual differences in response to treatment (e.g., Ganz, Davis, Lund, Goodwyn, & Simpson, 2012; Stahmer, Schreibman, & Cunningham, 2011 ). Yet the importance of these differences has long been recognised. In fact, Leo Kanner (1943) , in his original case series involving 11 children with ASD, noted that:
"…the eleven children whose histories have been briefly presented offer, as is to be expected, individual differences in the degree of their disturbances, the manifestation of specific features, the family constellation, and the step-by-step development in the course of years. But even a quick review of the material makes the emergence of a number of essential common characteristics appear innevitable" (p241-242).
Seventy years on, Camarata (in press) provides a powerful account of how this complex combination of core difficulties and individual differences currently impacts diagnostic and treatment science and practices in the field of ASD. He reminds us that the challenges we face cannot be divorced from shifting diagnostic criteria, a push for early diagnosis and intervention, and policy context in which there is increasing demand for evidence-based decision making. In this commentary, we suggest that although these individual differences pose problems for diagnosis and evaluating treatment programs, they may ultimately hold the key to predicting treatment outcomes.
The Problem with Individual Differences
In the absence of reliable biological markers, diagnosis for children with ASD currently relies on detailed and accurate description of their behaviour. As Camarata (in press) noted, although the task of identifying behaviours relevant to a diagnosis of ASD is relatively simple by the time children start school, identifying the same behaviours in children aged 12-24 months is difficult. Indeed, the push for children to be diagnosed earlier with the view to starting treatment sooner forces clinicians to make decisions about children's development at a stage when they are developing rapidly and, at times, sporadically. This is a developmental period in which a matter of days can mean the difference between a child 'lacking' or 'having' a specific behaviour of interest and in which developmental disorders Individual Differences in ASD 4 share considerable behavioural overlap. Accordingly, Camarata highlighted the risks of confusing ASD with speech sound disorder or language delay in the early years, and the need to diagnose based on the specific behavioural markers (e.g., lack of social engagement) that differentiate ASD from other disorders. We agree with Camarata that the task of identifying these ASD-specific behavioural markers may become more difficult due to the heterogeneity of conditions now grouped into the single 'entity' of Autism Spectrum Disorders in DSM-5 (Vivanti et al., 2013 ). Yet, while this potentially frustrating heterogeneity in clinical profiles and symptom presentation poses a challenge for diagnosis, understanding these individual differences in children's behavioural profiles may be crucial to accurately measuring, and ultimately predicting, treatment outcomes.
The Potential to Predict Outcomes
There is growing awareness within the ASD research community of the limitations of evaluating treatment outcomes based solely on group-level analyses. In our opinion, efforts to understand the mechanisms underlying individual differences in treatment response should be at the top of the autism research agenda, and treatment research should be reframed around (Ozonoff, 2011) . However, the results of both studies are potentially equally informative when considered with regard to (a) the hypothesised mechanism of action in each intervention and (b) the characteristics of children who did and did not respond to treatment in each trial.
The PACT study compared parent-mediated communication-focused intervention delivered in a clinic to treatment as usual in the community in a trial involving 152 preschool aged children with 'core autism' and their parents. Child-parent dyads in the PACT treatment group received 36 hours of 1:1 consultation from a speech therapist over 12 months. Green et al (2010) reported no difference in autism severity scores (as measured on the Autism Diagnostic Observation Schedule) or standardised language measures at follow-up, leading the authors to recommend against adding PACT intervention to treatment as usual for the reduction of ASD symptoms. However, there is possibly more to this story. The goal of the PACT intervention was to increase parental sensitivity and responsiveness to children's Individual Differences in ASD 5 communication, which, in turn, was hypothesised to provide enhanced social-communication opportunities. Therefore, the negative group results indicate that this particular mechanism (increased social communication opportunities built on parental responsiveness to children's cues), is unlikely to be an active ingredient supporting positive treatment outcomes for the majority of children with ASD. However, individual variability in response to treatment, as evidence by large standard deviations on most measures, suggests that some children responded well to treatment while others made few gains. It would be helpful to know more about the characteristics of children and parents who did and did not respond to treatment, in order to determine whether that particular mechanism is associated with outcomes for some children with ASD, although not the majority. Unfortunately, details regarding individual differences have not yet been reported.
In the ESDM trial, Dawson et al (2010) delivered an average of 15.2 hours per week of 1:1 early intensive behavioural intervention to 24 children with ASD, aged 18-30 months, over a period of 24 months. A comparison group of 24 children, matched for age, IQ, ASD symptom severity, and adaptive behaviour received an average 5.2 hours a week of treatment as usual in the community. At 24 months, the ESDM group had on average increased 17.6 standard score points above baseline compared with 7.0 points in the comparison group. The ESDM group had also maintained their rate of growth in adaptive behaviour while the comparison group showed greater delays. In considering the findings, we note that the hypothesised mechanism of action was an increased reward value associated with the provision of social learning opportunities, resulting in increased motivation to interact with and learn from others. The positive results at the group level suggest that increased motivation/reward for spontaneous social learning may be an important factor in treatment outcomes for many children with ASD. However, again, there was evidence of variability in individual outcomes. Detailed description of the profiles of responders and non-responders may provide insight into how this particular process may influence treatment outcomes in a particular subgroups of children.
Advances in Predicting Treatment Outcomes
The question of why children respond differently to treatment is often overlooked, but it is a critical. Available information on the characteristics of these children is very limited, with most studies indicating that children with lower IQ, or intellectual disability, are less likely to undergo positive gains (Howlin, 2003) . However, findings from single case experimental research involving children with intellectual disability and complex Individual Differences in ASD 6 communication needs (e.g., Trembath, Balandin, Togher, & Stancliffe, 2009; van der Meer et al., 2012) clearly demonstrate that even among a group of children with equally impaired cognition and communication, individual responses to the same treatment often differ markedly. To understand and learn from individual differences in treatment outcomes, we need to focus on more specific predictor variables that are based on hypothesised 'active ingredients' of intervention programs.
In an attempt to identify specific factors that predict treatment outcomes for children with ASD, Vivanti, Dissanayake, Zierhut, and Rogers (2012) Responsive Education and Prelinguistic Milieu Teaching (RPMT) for young children with ASD. They reported an association between object exploration (the number of objects touched during a play assessment) and response to intervention, whereby children who began the study with high levels of object exploration benefited more from PECS than RPMT, whereas the opposite was true for children who began with low levels of object exploration.
More recently, Fey, Yoder, Warren, and Bredin-Oja (2013) reported an association between object play and treatment intensity in a study of 64 children with developmental disabilities Individual Differences in ASD 7 who received Milieu Communication Teaching, whereby children who played with more objects at baseline benefited more from high-than from low-intensity treatment. Importantly, the participants included children with and without ASD, suggesting that object exploration holds some value in predicting treatment response, irrespective of diagnosis.
Implications for Research and Practice
Put together, the findings of these studies imply a need to distinguish between features that are relevant for diagnosis (where homogeneity is crucial) versus features that are relevant for prognosis (where individual variability is more important than average response) when it comes to research involving children with ASD. It appears that symptoms and impairments that are critical for accurate early diagnosis (e.g., behaviours that distinguish ASD from other conditions) such as social attention may be less relevant to predicting treatment outcomes.
Conversely, behaviour characteristics that do no reliably distinguish ASD from other conditions, such as poor imitative abilities and poor functional play, appear to be relevant for treatment outcomes in ASD and other developmental disabilities (Poon, Watson, Baranek, & Poe, 2012; Vivanti et al., 2012) . Moreover, factors that appear to be associated with positive versus poor treatment outcomes might be different across ASD subgroups and across treatment programs.
In considering how the study of individual differences in children with ASD may inform treatment research, Camarata noted that "when autism symptomology is precise and the interventions match the child's traits, one could plausibly hypothesize that such a study would be more likely to yield interpretable results" (pTBC). Our view is that early emerging ASD diagnostic features (i.e., the unifying features that underlie all children in the spectrum) are highly relevant to diagnosis and essential to accurately characterising children for the purposes of treatment research. However, we suggest that the magnitude or strength of these 'diagnostic' features may not relate strongly to treatment outcomes. Conversely, other features that may or may not be specific to children with ASD (e.g., object use), and that are not shared by all individuals on the spectrum, may prove critical to predicting treatment outcomes in the future and prospectively matching children to treatments most likely to suit their individual learning profiles. This line of investigation requires a new focus on the active ingredients that are supposed to promote treatment changes and a fine grained investigation of heterogeneity in response to treatment, with a particular focus on profiles of children who show the least response.
